About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Effect of Kidney Disease on Diabetic Medications
By
UC Davis Health Diabetes and Endocrinology Symposium
FEATURING
Shubha Ananthakrishnan
By
UC Davis Health Diabetes and Endocrinology Symposium
FEATURING
Shubha Ananthakrishnan
224 views
December 6, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Related Content
AUTOPLAY
ON
06:38
Allan Jaffe
What Does Elevated Troponin Mean in COVID-19?
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
57:35
PKD Foundation
Basics of PKD
Feat.
C. Gordon
21:19
Patricia Kao
Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…
38:09
Houston Methodist Hospital
Changing Payment and Coverage Landscapes of ESRD Care
Feat.
S. Lekha Tummalapalli
58:00
West Virginia State Rheumatology Society
2022 Updates on the Management of Lupus Nephritis
Feat.
M. Petri
38:09
Houston Methodist Hospital
Multimodal Integrative Approach to Kidney Disease: Dietary Managemen…
Feat.
K. Kalantar-Zadeh
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
13:43
Stanford Medicine
What's the Ideal Therapy for Obesity?
Feat.
A. Yeoh
34:04
The Texas Heart Institute
Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
Feat.
G. Bakris
09:00
Cecilia Bahit
The Best of AHA23 for the Primary Care Doctor
49:59
Scripps Health
Pre-Operative Medical Evaluation Update
Feat.
J. Diamant
15:25
Javed Butler
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
52:36
University of Colorado Department of Medicine
The 2024 Collins Distinguished Lectureship - Kidney Stones: Canary i…
Feat.
E. Worcester
49:44
PKD Foundation
Dialysis 101: Understanding Chronic Kidney Disease and Dialysis
Feat.
B. Cowley
23:24
Scripps Health
The Future of Kidney Disease (With a Nod to the Present)
Feat.
T. Henke